23.15 USD
-1.05 (-4.34%)
23.25 USD
+0.1 (+0.43%)
We assign a fundamental rating of 4 out of 10 to PRVA. PRVA was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability. PRVA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PRVA was profitable.
In the past year PRVA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
PRVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PRVA's Return On Assets of 1.34% is in line compared to the rest of the industry. PRVA outperforms 53.47% of its industry peers.
The Return On Equity of PRVA (2.56%) is comparable to the rest of the industry.
PRVA has a Return On Invested Capital (2.45%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRVA's Profit Margin of 0.89% is in line compared to the rest of the industry. PRVA outperforms 54.46% of its industry peers.
In the last couple of years the Profit Margin of PRVA has declined.
PRVA has a Operating Margin of 1.38%. This is comparable to the rest of the industry: PRVA outperforms 45.54% of its industry peers.
In the last couple of years the Operating Margin of PRVA has declined.
PRVA's Gross Margin of 10.17% is on the low side compared to the rest of the industry. PRVA is outperformed by 74.26% of its industry peers.
In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
PRVA has more shares outstanding than it did 1 year ago.
PRVA has more shares outstanding than it did 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.42 indicates that PRVA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.42, PRVA belongs to the top of the industry, outperforming 80.20% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.42 |
ROIC/WACC0.27
WACC8.98%
2.3 Liquidity
A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.67, PRVA is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.67, PRVA is doing good in the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.00% over the past year.
The Earnings Per Share has been growing slightly by 7.43% on average over the past years.
The Revenue has grown by 19.01% in the past year. This is quite good.
PRVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.17% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
The Earnings Per Share is expected to grow by 69.59% on average over the next years. This is a very strong growth
Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.73% on average per year.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 178.08, which means the current valuation is very expensive for PRVA.
Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.00. PRVA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 72.25 indicates a quite expensive valuation of PRVA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRVA is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.70. PRVA is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 178.08 | ||
| Fwd PE | 72.25 |
4.2 Price Multiples
62.38% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
PRVA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.72 | ||
| EV/EBITDA | 64.53 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
PRVA's earnings are expected to grow with 69.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.09
PEG (5Y)23.95
EPS Next 2Y70.67%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
No dividends for PRVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
23.15
-1.05 (-4.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.68%
Inst Owner Change0%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap2.85B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (39.01%)
Short Float %2.62%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)0.48%
PT rev (3m)3.18%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-41.97%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-19.32%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 178.08 | ||
| Fwd PE | 72.25 | ||
| P/S | 1.39 | ||
| P/FCF | 25.72 | ||
| P/OCF | 25.72 | ||
| P/B | 4.02 | ||
| P/tB | 7.71 | ||
| EV/EBITDA | 64.53 |
EPS(TTM)0.13
EY0.56%
EPS(NY)0.32
Fwd EY1.38%
FCF(TTM)0.9
FCFY3.89%
OCF(TTM)0.9
OCFY3.89%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.09
PEG (5Y)23.95
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.42 |
F-Score7
WACC8.98%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
Can you provide the valuation status for PRIVIA HEALTH GROUP INC?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for PRVA stock?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 178.08 and the Price/Book (PB) ratio is 4.02.
Can you provide the financial health for PRVA stock?
The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.